
Neuralink, the neurotechnology company co-founded by Tesla (NASDAQ:TSLA) CEO Elon Musk, has joined a clinical trial aimed at restoring vision with full or partial blindness through visual prostheses, commonly known as bionic eyes.
According to an update posted on the